ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 127 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,533,000 | +26.6% | 21,614 | -12.7% | 0.05% | +22.7% |
| Q2 2016 | $1,211,000 | +5.2% | 24,765 | +36.3% | 0.04% | +15.8% |
| Q1 2016 | $1,151,000 | +94.1% | 18,176 | +243.8% | 0.04% | +100.0% |
| Q4 2015 | $593,000 | -46.7% | 5,287 | -54.3% | 0.02% | -42.4% |
| Q3 2015 | $1,113,000 | -79.8% | 11,561 | -78.5% | 0.03% | -76.4% |
| Q2 2015 | $5,500,000 | +61.1% | 53,712 | -2.3% | 0.14% | +62.8% |
| Q1 2015 | $3,414,000 | – | 54,981 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |